-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Maintains Outperform on Replimune Group, Raises Price Target to $19

Benzinga·02/04/2026 14:35:37
Listen to the news
Wedbush analyst Robert Driscoll maintains Replimune Group (NASDAQ:REPL) with a Outperform and raises the price target from $18 to $19.